Journal
CLEVELAND CLINIC JOURNAL OF MEDICINE
Volume 71, Issue 7, Pages 551-560Publisher
CLEVELAND CLINIC
DOI: 10.3949/ccjm.71.7.551
Keywords
-
Categories
Ask authors/readers for more resources
Toxic chemotherapeutic agents are slowly being supplemented by a new generation of drugs that recognize specific targets in or on cancer cells. Although these molecular and genetic approaches are in their infancy, they hold the promise of more effective therapies with markedly fewer side effects. Several targeted agents are already approved by the US Food and Drug Administration (FDA) for use in malignancies, and numerous others are in clinical trials.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available